Announced Sat, 30 May · 23:27 IST

Outcome of Board Meeting

Going ConcernAdverse OpinionRelated Party TransactionsPat NegativeResults RestatedResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+10.8%1-day move
₹50.55
prior close
₹48.05
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+15.5+15.5+15.5+14.5+10.8+16.7+20.9+24.6+17.7+26.1+20.7+19.7
Up moveDown movePending
AI summary

Vaxfab Enterprises Ltd reported audited financial results for FY2026 (year ended March 31, 2026). The company's statutory auditors Chandabhoy & Jassoobhoy issued a DISCLAIMER of opinion on both standalone and consolidated financial statements, unable to express any opinion due to inadequate records from previous management. Key issues include: improper maintenance of books of accounts, unsupported sales/purchase/inventory records, unsecured loans granted and received without formal agreements and without balance confirmations, and non-compliance with MSMED Act. Standalone PAT grew from Rs 58.42 Lacs to Rs 363.80 Lacs (523% increase), but consolidated results show a net loss of Rs (463.08) Lacs versus profit of Rs 48.93 Lacs in prior year. The company operates in trading of goods with revenue of Rs 9,410.75 Lacs (standalone) and Rs 13,126.29 Lacs (consolidated). Cash flow from operations turned positive at Rs 1,304.97 Lacs compared to negative Rs 608.73 Lacs last year.

Likely market impact

The disclaimer of opinion is a serious red flag indicating severe governance and record-keeping failures under previous management. The stark difference between standalone profit and consolidated loss raises concerns about subsidiary/associate performance. Shareholders should exercise caution as the financial statements lack auditor assurance on accuracy and completeness.